Solid Biosciences Inc.
NASDAQSolid Biosciences heads into its June 10 earnings report with an unusual split: short interest climbing while the Street grows more bullish. The earnings event is the lens through which everything else reads this week. The stock lost 8.5% on Tuesday alone — its sharpest single-day drop in recent weeks — and is now down 4.4% over the past five days and 7.7% over the past month…
Snapshot as of 3 Jun 2026
Solid Biosciences heads into its June 10 earnings report with an unusual split: short interest climbing while the Street grows more bullish. The earnings event is the lens through which everything else reads this week.…
Solid Biosciences heads into its May 19 quarterly report with shorts retreating from a recent peak yet the stock still carrying one of the more elevated short positions in the gene therapy space. Short sellers have…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SLDB — free to start on ORTEX.
Sign up for free →Open SLDB on ORTEX